-
公开(公告)号:EP4333829A1
公开(公告)日:2024-03-13
申请号:EP22728125.0
申请日:2022-05-05
申请人: Centre National de la Recherche Scientifique (CNRS) , Centre Hospitalier Universitaire de Montpellier , Institut National de la Santé et de la Recherche Médicale (INSERM) , Institut Curie , UNIVERSITE DE MONTPELLIER
IPC分类号: A61K31/198 , A61K31/35 , A61K31/454 , A61K38/07 , A61P35/02
-
32.
公开(公告)号:EP4330909A1
公开(公告)日:2024-03-06
申请号:EP22725731.8
申请日:2022-04-25
申请人: UNIVERSITE DE BORDEAUX , Institut National de la Santé et de la Recherche Médicale , Centre National de la Recherche Scientifique , Institut Polytechnique de Bordeaux
-
公开(公告)号:EP4327101A1
公开(公告)日:2024-02-28
申请号:EP22724071.0
申请日:2022-04-21
申请人: SORBONNE UNIVERSITE , Institut national de la santé et de la recherche médicale (INSERM) , Assistance Publique - Hôpitaux de Paris
发明人: MARQUES, Cindy , REGNIER, Paul , SAADOUN, David
IPC分类号: G01N33/564 , C07K16/00
-
34.
公开(公告)号:EP4314246A1
公开(公告)日:2024-02-07
申请号:EP22717405.9
申请日:2022-03-31
-
公开(公告)号:EP4313015A1
公开(公告)日:2024-02-07
申请号:EP22712952.5
申请日:2022-03-23
-
公开(公告)号:EP4309733A1
公开(公告)日:2024-01-24
申请号:EP22306096.3
申请日:2022-07-22
申请人: Institut National de la Santé et de la Recherche Médicale (INSERM) , Université Paris Cité , Sorbonne Université , Assistance Publique-Hôpitaux de Paris (APHP)
摘要: Cardiomyopathies are heart muscle disorders which represent a heterogeneous group of diseases that often lead to progressive heart failure with significant morbidity and mortality. Here, the inventors show that neutralization of ACBP/DBI reduces the deleterious effect of the anthracycline doxorubicin on cardiac function. Since anthracycline-induced heart failure is a model of accelerated cardiac aging, it is also plausible to use ACBP/DBI inhibition or neutralization as a method to prevent or treat aging of the cardiovascular system. The inventors also found that genetic and pharmacological interventions to deplete ACBP efficiently improve cardiac dysfunction associated with experimental HFpEF, a condition associated with aging, hypertension and obesity. Accordingly, the present invention relates to methods for the treatment of cardiac dysfunction comprising neutralization of Acyl-CoA Binding Protein.
-
公开(公告)号:EP4308690A1
公开(公告)日:2024-01-24
申请号:EP22715349.1
申请日:2022-03-18
申请人: Université Paul Sabatier Toulouse III , Institut National de la Santé et de la Recherche Médicale (INSERM) , Centre Hospitalier Universitaire De Toulouse , Centre Hospitalier Universitaire de Montpellier , UNIVERSITE DE MONTPELLIER , Arthritis Recherche & Developpement
发明人: CLAVEL, Cyril , SERRE, Guy, Bruno, René , MARTINEAU, Pierre , ALLENDE-VEGA, Nerea , APPARAILLY, Florence , VILLALBA, Martin , JORGENSEN, Christian
IPC分类号: C12N5/0783 , C12N5/0786 , C07K14/47 , A61P37/00 , A61P19/02 , A61K35/15 , A61K35/17 , C07K14/75 , C07K14/735
-
公开(公告)号:EP4308132A1
公开(公告)日:2024-01-24
申请号:EP22713425.1
申请日:2022-03-16
申请人: Technische Universität Dresden , Centre National de la Recherche Scientifique (CNRS) , Université d'Aix-Marseille , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: SIEWEKE, Michael , ELENDNER, Clara Jana Lui , FAVRET, Jeremy , SARRAZIN, Sandrine , QODS, Lahmar
IPC分类号: A61K35/15 , C12N5/0786
-
公开(公告)号:EP4308059A1
公开(公告)日:2024-01-24
申请号:EP22715175.0
申请日:2022-03-18
-
公开(公告)号:EP4304634A1
公开(公告)日:2024-01-17
申请号:EP22712928.5
申请日:2022-03-11
申请人: Institut Curie , Mnemo Therapeutics , INSERM (Institut National de la Santé et de la Recherche Médicale)
-
-
-
-
-
-
-
-
-